FLUDEOXYGLUCOSE BIONT 200-2200 MBQ/ml 200-1300mbq/ml solution for injection
fludeoxyglucose (18F) Indicated for: diagnostic imaging
V09IX04 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection
letter F · page 27
fludeoxyglucose (18F) Indicated for: diagnostic imaging
V09IX04 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection
indapamide + amlodipine Indicated for: hypertension
C08GA02 Cardiovascular system | Calcium channel blockers | Calcium channel blockers and diuretics
indapamide + amlodipine Indicated for: hypertension
C08GA02 Cardiovascular system | Calcium channel blockers | Calcium channel blockers and diuretics
live attenuated flu vaccine Indicated for: prevention of influenza
J07BB03 Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
live attenuated flu vaccine Indicated for: prevention of influenza
J07BB03 Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
povidone Indicated for: pharmaceutical excipient
carbocisteine Indicated for: respiratory disorders with viscous secretions
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
carbocisteine Indicated for: respiratory disorders with viscous secretions
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
carbocisteine Indicated for: respiratory disorders with viscous secretions
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
flumazenil Indicated for: reversal of benzodiazepine effects
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
flumazenil Indicated for: reversal of benzodiazepine effects
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
flumazenil Indicated for: reversal of benzodiazepine effects
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
flumazenil Indicated for: reversal of benzodiazepine effects
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
fluorometholone + tetrahydrozoline Indicated for: ocular inflammation
S01BB03 Sensory organs | Antiinflammatory agents | Corticosteroids and mydriatics in combination